The July/August issue of @EPM_magazine is available for download with all the regulars and features on legal — IP, sterilisation, ACHEMA review, excipients, personalised medicine plus a drug delivery supplement.
EPM July/August 2018
In this issue:
- Editor's desk — assessing the impact Amazon may have on the pharma space.
- A small dose — a brief round-up of some of the developments in the industry including the revelation that many of us are taking too many NSAIDs and the latest on medical marijuana.
- Analysis — IDBS discusses the potential of big data and what barriers are left to overcome before its widespread use.
- Opinion — looking at patient centricity in pharmaceuticals and how it may help with medication adherence.
- Regulatory affairs — here, we speak with Six Degrees Medical about the impact of GDPR on pharma.
- Cover story — Natoli highlights the critical issue of powder flow and how solving issues before production can reduce issues down the line.
- Drug Delivery Supplement — in this special supplement several topics are considered, including how connected drug delivery can help with adherence, transdermal solutions and innovative method.
- Legal — IP — looking at why it is essential for businesses to insure their intellectual property and the proposal of the manufacturing exemption for SPCs in more detail.
- Sterilisation — investigating the use of wireless dataloggers for autoclave validation.
- ACHEMA Review — we speak innovations, present trends and what we should expect at the next event with five key manufacturing companies at the show.
- Excipients — summarising the benefits of an excipient GMP certification programme.
- Personalised Medicine — detailing why integrating and automating cell therapy production with MES will help sector growth.
- Tech talk — this instalment sees the comparison between pharma and digital start-ups in the field of mHealth.
The latest digital issue is available for download FREE on iOS and Android devices.